NTAGI may meet on Friday to review Covovax, Corbevax

Both SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines for the children going forward.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mPjAN9yUB
via IFTTT